Chinese medical device manufacturers are increasingly targeting European markets as an alternative growth strategy, facing mounting regulatory scrutiny and investigations in their domestic healthcare sector. While Europe presents significant expansion opportunities, these companies must navigate stringent regulatory requirements, certification standards, and growing protectionist measures from established Western competitors. Success requires strategic adaptation to EU compliance frameworks and competitive differentiation beyond cost advantages.

Summary auto-generated by AI from the original publisher's content. Editorial standards.